Back to Search
Start Over
Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
- Source :
-
Life sciences [Life Sci] 2021 Feb 15; Vol. 267, pp. 118978. Date of Electronic Publication: 2021 Jan 05. - Publication Year :
- 2021
-
Abstract
- Aims: Vascular smooth muscle cell (VSMC) phenotype shift is involved in the pathophysiology of vascular injury or platelet-derived growth factor (PDGF)-induced abnormal proliferation and migration of VSMCs. We aimed to investigate the underlying mechanism involved in PDGF-mediated signaling pathways and autophagy regulation followed by VSMC phenotype shift.<br />Main Methods: The proliferation, migration and apoptosis of cultured rat aortic VSMCs were measured, and cells undergoing phenotype shift and autophagy were examined. Specific inhibitors for target proteins in signaling pathways were applied to clarify their roles in regulating cell functions.<br />Key Findings: PDGF-BB stimulation initiated autophagy activation and synthetic phenotype transition by decreasing α-smooth muscle-actin (SMA), calponin and myosin heavy chain (MHC) and increasing osteopontin (OPN) expression. However, U0126, a potent extracellular signal-regulated kinase 1/2 (Erk1/2) inhibitor, decreased PDGF-BB-induced LC3 expression, while rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR), increased it. Furthermore, U0126 decreased the expresseion of autophagy-related genes (Atgs) such as beclin-1, Atg7, Atg5, and Atg12-Atg5 complex, indicating that Erk1/2 is a regulator of PDGF-BB-induced VSMC autophagy. Regardless of autophagy inhibition by U0126 or activation by rapamycin, the PDGF-BB-induced decrease in SMA, calponin and MHC and increase in OPN expression were inhibited. Furthermore, PDGF-BB-stimulated VSMC proliferation, migration and proliferating cell nuclear antigen (PCNA) expression were inhibited by U0126 and rapamycin.<br />Significance: These findings suggest that PDGF-BB-induced autophagy is strongly regulated by Erk1/2, an mTOR-independent pathway, and any approach for targeting autophagy modulation is a potential therapeutic strategy for addressing abnormal VSMC proliferation and migration.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Becaplermin genetics
Becaplermin pharmacology
Calcium-Binding Proteins
Cell Movement drug effects
Cell Proliferation drug effects
Cells, Cultured
MAP Kinase Signaling System physiology
Microfilament Proteins
Mitogen-Activated Protein Kinase 3 metabolism
Myocytes, Smooth Muscle metabolism
Myosins
Phenotype
Proliferating Cell Nuclear Antigen metabolism
Proto-Oncogene Proteins c-sis metabolism
Rats
Signal Transduction drug effects
TOR Serine-Threonine Kinases metabolism
Calponins
Autophagy physiology
Becaplermin metabolism
Muscle, Smooth, Vascular metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0631
- Volume :
- 267
- Database :
- MEDLINE
- Journal :
- Life sciences
- Publication Type :
- Academic Journal
- Accession number :
- 33412209
- Full Text :
- https://doi.org/10.1016/j.lfs.2020.118978